SEARCH

SEARCH BY CITATION

References

  • 1
    Tomizuka T, Takayama Y, Shobayashi T, Fukushima Y, Suzuki Y. Underlying medical conditions and hospitalization for pandemic (H1N1) 2009, Japan. Emerg Infect Dis 2010; 16: 16467.
  • 2
    Helferty M, Vachon J, Tarasuk J, et al. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 2010; 182: 19817.
  • 3
    Naseem A, Satti S, Khan MA, Saeed W. A clinical account of hospitalized 2009 pandemic influenza A (H1N1) cases. J Coll Physicians Surg Pak 2011; 21: 97102.
  • 4
    Duchini A, Viernes ME, Nyberg LM, Hendry M, Pockros PJ. Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch Intern Med 2000; 160: 1135.
  • 5
    Fiore AE, Shay DK, Haber P, et al. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56: 154.
  • 6
    Song JY, Cheong HJ, Ha SH, et al. Clinical impact of influenza immunization in patients with liver cirrhosis. J Clin Virol 2007; 39: 15963.
  • 7
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 6469.
  • 8
    Bridges CB, Katz JM, Levandowski RA, Cox NJ. Influenza vaccine (inactivated). In: Plotkin S, Orenstein W, Offit P, eds. Vaccines. Philadelphia: Elsevier, 2008: 25990.
  • 9
    Osaka Prefectural Institute of Public Health. The weekly number of clinical influenza cases reported by sentinels. Available at: http://www.iph.pref.osaka.jp/infection/2-old.html. Accessed 23 May 2011.
  • 10
    Emnorg HD, Krause TG, Hvvid A, Simonsen J, Molbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009/10. BMJ 2011; 344: d7901.
  • 11
    Steens A, Wijnans EG, Dieleman JP, et al. Effectiveness of a MF-59TM-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalization; a matched case-control study. BMC Infect Dis 2011; 11: 196.
  • 12
    Ohfuji S, Fukushima W, Tamori A, et al. Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C. Influenza Other Respi Viruses 2012; 7: 45665.
  • 13
    Gaeta GB, Pariani E, Amendola A, et al. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine 2009; 27: 33735.
  • 14
    Gaeta GB, Stornaiuolo G, Precone DF, Amendola A, Zanetti AR. Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis. Vaccine 2002; 20: B335.
  • 15
    Soesman NMR, Rimmelzwaan GF, Nieuwkoop NL, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000; 61: 8593.
  • 16
    World Health Organization. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec 2012; 87: 46176.
  • 17
    Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 193544.
  • 18
    Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection in patients before and after liver transplantation. Liver Transpl 2000; 6: 53142.
  • 19
    Fukui H. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcohol Clin Exp Res 2005; 29: S1729.
  • 20
    Louie JK, Acosta M, Winter K, et al. for the California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302: 1896902.
  • 21
    Kumar A, Zarychanski R, Pinto R, et al. for the Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302: 18729.
  • 22
    The ANZIC influenza investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361: 192534.
  • 23
    Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302: 18807.
  • 24
    Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 493504.
  • 25
    Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 77884.
  • 26
    Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 194552.